EUVIMEDEUVIMED entdecken
Crossref

Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy

Yao Chen, Lan-Ping Xu, Xiao-Hui Zhang, Huan Chen, Kai-Yan Liu, Jiong Qing, Yan-Ling Yang, Xiao-Jun Huang iD

Pediatric Transplantation · 2024-05 · 28 (3)

DOI: 10.1111/petr.14735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, online erschienen am 11.04.2024. Verfasst von Yao Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Adrenoleukodystrophy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We investigated the safety and efficacy of haploidentical stem cell transplantation (SCT) in pediatric patients with X‐linked adrenoleukodystrophy (ALD).

Methods

A retrospective analysis of transplantation data from 29 cases of ALD, treated between December 2014 and April 2022, was conducted. Neurologic function scores (NFS) were assessed. The conditioning regimen was busulfan 9.6 mg/kg, cyclophosphamide 200 mg/kg, and fludarabine 90 mg/m 2 (BFC). Graft‐versus‐host disease prophylaxis consisted of anti‐human thymocyte globulin, cyclosporine A, mycophenolate mofetil, and short course of methotrexate.

Results

Among the 29 cases, 14 cases (NFS = 0) were asymptomatic, and 15 (NFS ≥ 1) were symptomatic. The median age at SCT was 8 years (range: 4–16 years); the median follow‐up time was 1058 days (range: 398–3092 days); 28 cases were father donors and 1 case was a grandfather donor. Hematopoietic reconstitution was successful in all patients, and all of them achieved complete donor chimerism at the time of engraftment. The leading cause of death was still primary disease progression ( n = 4). Survival free of major functional disabilities was 100% in asymptomatic patients versus 66.67% in the symptomatic group ( p = .018).

Conclusion

BFC regimen used in haploidentical SCT was administered safely without major transplant‐related complications even in symptomatic patients, and neurological symptoms were stabilized after SCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAdrenoleukodystrophyHumansChildChild, PreschoolAdolescentBusulfanRetrospective StudiesTransplantation ConditioningCyclophosphamideAntilymphocyte SerumVidarabine

Stichwörter der Autor:innen

adrenoleukodystrophyengraftmentgraft‐versus‐host diseasehaploidenticalstem cell transplantation

Substanzen

BusulfanfludarabineCyclophosphamideAntilymphocyte SerumVidarabine

Autor:innen und Institutionen

  • Peking University People's Hospital, Beijing, China.
  • Peking University Institute of Hematology, Beijing, China.
  • National Clinical Research Center for Hematologic Disease, Beijing, China.
  • Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
  • First Hospital Peking University, Beijing, China.

ORCID-Profile: Xiao-Jun Huang

Zitieren

APA

Chen, Y., Xu, L. P., Zhang, X. H., Chen, H., Liu, K. Y., Qing, J., Yang, Y. L., & Huang, X. J. (2024). Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy. Pediatric Transplantation, 28(3). https://doi.org/10.1111/petr.14735

Vancouver

Chen Y, Xu LP, Zhang XH, Chen H, Liu KY, Qing J, et al. Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy. Pediatric Transplantation. 2024;28(3). doi:10.1111/petr.14735

BibTeX
@article{Chen2024,
  author = {Chen, Yao and Xu, Lan-Ping and Zhang, Xiao-Hui and Chen, Huan and Liu, Kai-Yan and Qing, Jiong and Yang, Yan-Ling and Huang, Xiao-Jun},
  title = {Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy},
  journal = {Pediatric Transplantation},
  year = {2024},
  volume = {28},
  number = {3},
  doi = {10.1111/petr.14735}
}
Kostenlos starten →